First Patient With Multiple Myeloma Dosed in EsoBiotec's Trial for In Vivo CAR-T ESO-T01

Retrieved on: 2025-01-09 22:21:52

Tags for this article:

Click the tags to see associated articles and topics

First Patient With Multiple Myeloma Dosed in EsoBiotec's Trial for In Vivo CAR-T ESO-T01. View article details on hiswai:

Excerpt

... Biopharma's BCMA CAR-T transgene. EsoBiotec states that their approach ... https://www.umoja-biopharma.com/news/umoja-biopharma-announces-fda ...

Article found on: www.cgtlive.com